DFIB Cardiac Science (MM)

Cardiac Science Files 2004 Form 10-K IRVINE, Calif., March 23 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB) today reported that it filed its Annual Report on Form 10-K with the Securities and Exchange Commission on Wednesday, March 16, 2005. Interested parties may access the filing by visiting http://www.sec.gov/ or by requesting the document from Cardiac Science directly for free by contacting Investor Relations at (949) 474-4300. As was the case with the Company's prior Annual Reports, the Form 10-K for the year ended December 31, 2004 contained a report with a "going-concern" explanatory paragraph from its independent registered public accounting firm, PricewaterhouseCoopers, LLP, based on the Company's history of operating losses. In addition, the independent registered public accounting firm expressed an opinion that management's assessment of the Company's internal controls over financial reporting as of December 31, 2004, was fairly stated, in all material respects, based on criteria established in Internal Control -- Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Furthermore, in the opinion of the independent registered public accounting firm, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on criteria established by COSO. This announcement is in compliance with the Nasdaq Rule 4350(b) requiring separate disclosure of receipt of an audit opinion that contains a going- concern explanatory paragraph. About Cardiac Science Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automated public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The company makes the Powerheart(R) CRM(R), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information please visit http://www.cardiacscience.com/ or call (949) 797-3800. Contact: Matt Clawson (Investors), or Roderick de Greef Len Hall (Media) Chief Financial Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science, Inc. CONTACT: investors, Matt Clawson, , or media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Roderick de Greef, Chief Financial Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.cardiacscience.com/

Copyright